This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2003 Remove Healthcare Remove Pharmaceutical research Related Topics
Side effects Pharmacology Pharmaceutical Sales Prescription Food and Drug Administration Healthcare Competition Networking Safety Patients More Related Topics >
article thumbnail

Paving the way for anti-Abeta active immunotherapy

European Pharmaceutical Review

SEPTEMBER 22, 2023

Active immunotherapy through vaccination has a far lower cost than mAb-based therapies, representing an important decrease of economic burden for healthcare systems at a global scale. Andrea Pfeifer, PhD In 2003, Andrea Pfeifer co-founded AC Immune SA. She is currently CEO and successfully led the IPO on Nasdaq in 2016.

Food and Drug Administration 78
Food and Drug Administration Safety Patients Leads 78
article thumbnail

Beating the Big C

Pharmaceutical Technology

JULY 23, 2008

” “Between 2003 and 2005 global sales for cancer-treating drugs grew by 40%.” “There’s a huge clinical need which has been undelivered for years,” says Gustav Ando, manager of the healthcare business development unit [HBDU] at Global Insight.

Side effects 52
Side effects Marketing Pharmaceutical Sales 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 8,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024